Read more

January 18, 2020
1 min read
Save

Management of postop ptosis depends on severity

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Don Kikkawa at Hawaiian Eye 2020
Don O. Kikkawa

KOLOA, Hawaii — Ptosis is a relatively common but under-recognized risk of intraocular surgery, including cataract surgery, according to a presenter at Hawaiian Eye 2020.

“Patients should be aware that ptosis is a risk, but thankfully most of the time, it corrects itself over time or it’s something we can fix,” Don O. Kikkawa, MD, FACS, the Dr. Trude Kahn Hollander Chair in Ophthalmology at the University of California San Diego Shiley Eye Institute, said.

General risk factors for ptosis include older age, trauma, contact lens use, topical ocular medications and ocular procedures, according to Kikkawa.

“Ptosis can be seen relatively frequently after intraocular procedures, sometimes as high as 20%,” Kikkawa said, citing speculum use, superior rectus bridle sutures, anesthetic toxicity and postoperative inflammation, as possible contributing factors.

When postoperative ptosis does occur, the condition should be observed for up to 6 months, he said. Whereas mild ptosis may resolve, severe ptosis may require surgical intervention.

For symptomatic ptosis, muellerectomy or external levator advancement can provide good repair, he said. If the ptosis is 2 mm or less, a posterior approach should be used with phenylephrine testing to confirm proper muscle function. When the ptosis is 3 mm or greater, then an anterior levator approach should be considered, he said.

“If there is unresolved ptosis after the procedure and after a 6-month waiting period, surgery can be considered and is typically successful,” Kikkawa said. – by Alaina Tedesco

Reference: Kikkawa DO. When the lights go down in the city: Ptosis after ocular surgery. Presented at: Hawaiian Eye 2020; Jan. 18-24, 2020; Koloa, Hawaii.

Disclosure: Kikkawa reports receiving book royalties from Elsevier and consulting for Horizon Therapeutics.